Scientists have reported that the tiny light-sensing cells known as rods have been clearly and directly imaged in the living eye for the first time. Using adaptive optics (AO), the same technology astronomers use to study distant stars and galaxies, sc…
Category: News
Criteria Identified For Medical Management Of Pediatric Orbital Cellulitis
Researchers from Hasbro Children’s Hospital in Providence, R.I., report that medical management may be preferred over surgery for children with orbital cellulitis, an acute infection of the tissues surrounding the eye. They have determined the criteria…
LasikPlus® Launches Eye Can Tell You A Story Contest
LasikPlus®, a leading provider of laser vision correction, is searching for stories about how their services have changed the lives of people treated at LasikPlus. The company is hosting a contest on its Facebook page (http://www.facebook.com/LasikPlu…
Medical management preferred over surgery for pediatric orbital cellulitis
Researchers from Hasbro Children’s Hospital in Providence, R.I., report that medical management may be preferred over surgery for children with orbital cellulitis, an acute infection of the tissues surrounding the eye. They have determined the criteria…
Patient Motivation, Adaptability Crucial For Presbyopia Correction
The key ingredients to successful presbyopia correction may be a patient’s drive and flexibility, according to a presenter here.
Historic First Images Of Rod Photoreceptors In The Living Human Eye
WASHINGTON, June 8-Scientists today reported that the tiny light-sensing cells known as rods have been clearly and directly imaged in the living eye for the first time. Using adaptive optics (AO), the same technology astronomers use to study distant st…
Treating Epiphora Part One: Diagnosis and Solutions from FCI
Technology Spotlight
Treating Epiphora Part Two: Repair of a Canalicular Laceration
Technology Spotlight
First Head-to-Head Study In Branch Retinal Vein Occlusion(BRVO) Announced In Europe And Israel
Allergan Ltd. announced today the first head-to-head study in branch retinal vein occlusion (BRVO), a sight threatening eye condition that impacts approximately 300,000 people in the EU each year1,2…
Trial Of Drug’s Impact On Neurological Disease Affecting Women
A rare but increasingly more common disease striking overweight, younger women is the focus of a clinical trial at Michigan State University, where an osteopathic physician is testing the effectiveness of a certain drug against a potentially blindness-…
Early Detection May Prevent Blindness, Australia
A leading cause of blindness, age-related macular degeneration (AMD), may be detected in healthy people at risk of developing the disease thanks to the discovery of a technique for early detection by researchers at Queensland University of Technology (…
New Westchester Montefiore Laser and Eye Center to offer ophthalmology services
The new Montefiore Laser and Eye Center recently opened its doors to provide comprehensive care to Westchester patients at the Montefiore Medical Specialists of Westchester in Scarsdale, New York. Seven board-certified ophthalmologists from the Departm…
Researchers Find That Inhibiting MicroRNAs May Help Prevent Degenerative Eye Disorders
Blocking two tiny molecules of RNA a chemical cousin of DNA appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found…
Tocagen’s First-in-Human Clinical Trial Of Toca 511 Enrolling Patients With High Grade Glioma
Tocagen Inc. announced the company is enrolling patients with recurrent high grade glioma, such as those with glioblastoma multiforme (GBM, Grade 4), in its first-in-human clinical trial of Toca 511…
MSU professor to lead acetazolamide clinical trial on idiopathic intracranial hypertension
A rare but increasingly more common disease striking overweight, younger women is the focus of a clinical trial at Michigan State University, where an osteopathic physician is testing the effectiveness of a certain drug against a potentially blindness-…
Researchers Find That Inhibiting MicroRNAs May Help Prevent Degenerative Eye Disorders
DALLAS – June 7, 2011 – Blocking two tiny molecules of RNA – a chemical cousin of DNA – appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have found.
‘A Sticky Situation’ – Part I
Featured Article
Johns Hopkins Study Demonstrates 16% Increase In Patient Adherence Using MEMOTEXT And Microsoft HealthVault In The First Randomized Clinical Trial Of Its Kind In North America.
MEMOTEXT presented “The Impact of Automated Dosing Reminders on Medication Adherence Using HealthVault,” conducted by Johns Hopkins University and funded by the Microsoft HealthVault Be Well Fund at Mobile Health 2011: What Really Works conference at S…
20-20 Vision Perfection Based At The Manchester Face And Eye Clinic First To Offer Innovative Keratoconus Treatment In The United Kingdom
20-20 Vision Perfection announces that it has acquired advanced technology for performing Keraflex™ and KXL™, two new, non-invasive, non-surgical procedures used in combination to treat keratoconus. Mr…
CE Gives Green Light To Dexamethasone For The Treatment Of Common Eye Condition In Draft Guidance
In final draft guidance published today NICE has recommended dexamethasone (Ozurdex, Allergan) intravitreal implant, for the treatment of macular oedema following central retinal vein occlusion (CRVO)i…